491 related articles for article (PubMed ID: 32156116)
1. Multitarget Approaches against Multiresistant Superbugs.
Gray DA; Wenzel M
ACS Infect Dis; 2020 Jun; 6(6):1346-1365. PubMed ID: 32156116
[TBL] [Abstract][Full Text] [Related]
2. How many modes of action should an antibiotic have?
Brötz-Oesterhelt H; Brunner NA
Curr Opin Pharmacol; 2008 Oct; 8(5):564-73. PubMed ID: 18621146
[TBL] [Abstract][Full Text] [Related]
3. Targeting bacterial topoisomerases: how to counter mechanisms of resistance.
Tse-Dinh YC
Future Med Chem; 2016 Jun; 8(10):1085-100. PubMed ID: 27285067
[TBL] [Abstract][Full Text] [Related]
4. When Humans Met Superbugs: Strategies to Tackle Bacterial Resistances to Antibiotics.
Bravo A; Ruiz-Cruz S; Alkorta I; Espinosa M
Biomol Concepts; 2018 Dec; 9(1):216-226. PubMed ID: 30811343
[TBL] [Abstract][Full Text] [Related]
5. Multitarget ligands in antibacterial research: progress and opportunities.
East SP; Silver LL
Expert Opin Drug Discov; 2013 Feb; 8(2):143-56. PubMed ID: 23252414
[TBL] [Abstract][Full Text] [Related]
6. Genomic tools to profile antibiotic mode of action.
Cardona ST; Selin C; Gislason AS
Crit Rev Microbiol; 2015; 41(4):465-72. PubMed ID: 24617440
[TBL] [Abstract][Full Text] [Related]
7. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV
Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762
[TBL] [Abstract][Full Text] [Related]
8. Systems-Level Chemical Biology to Accelerate Antibiotic Drug Discovery.
Farha MA; French S; Brown ED
Acc Chem Res; 2021 Apr; 54(8):1909-1920. PubMed ID: 33787225
[TBL] [Abstract][Full Text] [Related]
9. Novel Antibacterial Compounds and their Drug Targets - Successes and Challenges.
Kaczor AA; Polski A; Sobótka-Polska K; Pachuta-Stec A; Makarska-Bialokoz M; Pitucha M
Curr Med Chem; 2017; 24(18):1948-1982. PubMed ID: 27978802
[TBL] [Abstract][Full Text] [Related]
10. Targeted antibiotic discovery through biosynthesis-associated resistance determinants: target directed genome mining.
O'Neill EC; Schorn M; Larson CB; Millán-Aguiñaga N
Crit Rev Microbiol; 2019 May; 45(3):255-277. PubMed ID: 30985219
[TBL] [Abstract][Full Text] [Related]
11. Prospects for Antibacterial Discovery and Development.
Privalsky TM; Soohoo AM; Wang J; Walsh CT; Wright GD; Gordon EM; Gray NS; Khosla C
J Am Chem Soc; 2021 Dec; 143(50):21127-21142. PubMed ID: 34860516
[TBL] [Abstract][Full Text] [Related]
12. Synchronous application of antibiotics and essential oils: dual mechanisms of action as a potential solution to antibiotic resistance.
Owen L; Laird K
Crit Rev Microbiol; 2018 Aug; 44(4):414-435. PubMed ID: 29319372
[TBL] [Abstract][Full Text] [Related]
13. Thinking Outside the Box-Novel Antibacterials To Tackle the Resistance Crisis.
Lakemeyer M; Zhao W; Mandl FA; Hammann P; Sieber SA
Angew Chem Int Ed Engl; 2018 Oct; 57(44):14440-14475. PubMed ID: 29939462
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting conjugation as a tool in the fight against antibiotic resistance.
Graf FE; Palm M; Warringer J; Farewell A
Drug Dev Res; 2019 Feb; 80(1):19-23. PubMed ID: 30343487
[TBL] [Abstract][Full Text] [Related]
15. The Combination of Antibiotic and Non-Antibiotic Compounds Improves Antibiotic Efficacy against Multidrug-Resistant Bacteria.
Xiao G; Li J; Sun Z
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895172
[TBL] [Abstract][Full Text] [Related]
16. Using experimental evolution to identify druggable targets that could inhibit the evolution of antimicrobial resistance.
Mehta HH; Prater AG; Shamoo Y
J Antibiot (Tokyo); 2018 Feb; 71(2):279-286. PubMed ID: 28928474
[TBL] [Abstract][Full Text] [Related]
17. Combating bacteria and drug resistance by inhibiting mechanisms of persistence and adaptation.
Smith PA; Romesberg FE
Nat Chem Biol; 2007 Sep; 3(9):549-56. PubMed ID: 17710101
[TBL] [Abstract][Full Text] [Related]
18. The Role of Mass Spectrometry in the Discovery of Antibiotics and Bacterial Resistance Mechanisms: Proteomics and Metabolomics Approaches.
Cuevas-Cruz M; Hernández-Guzmán U; Álvarez-Rosales PC; Schnabel M; Gómez-Manzo S; Arreguín-Espinosa R
Curr Med Chem; 2022; 30(1):30-58. PubMed ID: 35352637
[TBL] [Abstract][Full Text] [Related]
19. Strategies to Overcome Antimicrobial Resistance (AMR) Making Use of Non-Essential Target Inhibitors: A Review.
Annunziato G
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766441
[TBL] [Abstract][Full Text] [Related]
20. Restoring and Enhancing the Potency of Existing Antibiotics against Drug-Resistant Gram-Negative Bacteria through the Development of Potent Small-Molecule Adjuvants.
Yu B; Roy Choudhury M; Yang X; Benoit SL; Womack E; Van Mouwerik Lyles K; Acharya A; Kumar A; Yang C; Pavlova A; Zhu M; Yuan Z; Gumbart JC; Boykin DW; Maier RJ; Eichenbaum Z; Wang B
ACS Infect Dis; 2022 Aug; 8(8):1491-1508. PubMed ID: 35801980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
